To summarize, a growing body of evidence suggests that DYRK2 is mainly involved in neuroblastoma, glioma, epilepsy, and neuroinflammation but also could be involved in traumatic and neurodegenerative diseases and Rabies virus infection. Here, DYRK2 is linked to glioma.